SCHEMBL26473067

SCHEMBL26473067

CCOc1cc(-c2cccnc2)c(OC)cc1C

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 2/20 0.51
▸ NPC1 O15118 1/20 0.51
▸ CYP11B1 P15538 7/20 0.49
▸ CYP11B2 P19099 7/20 0.49
▸ CYP19A1 P11511 6/20 0.49
▸ ALPL P05186 2/20 0.49
▸ MKNK1 Q9BUB5 2/20 0.49
▸ MKNK2 Q9HBH9 2/20 0.49
▸ CYP3A4 P08684 2/20 0.48
▸ ALDH1A1 P00352 2/20 0.47
▸ KDM4E B2RXH2 1/20 0.47
▸ HPGD P15428 1/20 0.47
▸ MAPK1 P28482 1/20 0.47
▸ NPSR1 Q6W5P4 1/20 0.47
▸ HSD17B10 Q99714 1/20 0.47
▸ PDE10A Q9Y233 1/20 0.46
▸ PDGFRB P09619 1/20 0.45
▸ PDGFRA P16234 1/20 0.45
▸ CYP17A1 P05093 1/20 0.45
▸ AAK1 Q2M2I8 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26473138 0.95 CYP11B1 (0.54) MAPTNPC1CYP11B1CYP11B2CYP19A1
SCHEMBL26473085 0.93 CYP11B1 (0.55) MAPTNPC1CYP11B1CYP11B2CYP19A1
SCHEMBL23326169 0.89 MKNK1 (0.56) MAPTNPC1CYP11B1CYP11B2CYP19A1
SCHEMBL29775379 0.89 MKNK1 (0.56) MAPTNPC1CYP11B1CYP11B2CYP19A1
SCHEMBL23326124 0.85 MKNK1 (0.51) MAPTNPC1CYP11B1CYP11B2CYP19A1
SCHEMBL26473195 0.83 PDE10A (0.48) MAPTNPC1CYP11B1CYP11B2CYP19A1
SCHEMBL23326295 0.83 CYP11B1 (0.54) MAPTNPC1CYP11B1CYP11B2CYP19A1
SCHEMBL29775344 0.83 CYP11B1 (0.54) MAPTNPC1CYP11B1CYP11B2CYP19A1
SCHEMBL23326266 0.82 NPC1 (0.47) MAPTNPC1CYP11B1CYP11B2CYP19A1
SCHEMBL26473271 0.82 MKNK1 (0.52) CYP11B1CYP11B2CYP19A1MKNK1MKNK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11642336-B2 5-HT2A agonists for use in treatment of depression Lophora ApS (DK) 2023-05-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11642336-B2 5-HT2A agonists for use in treatment of depression HTR2A, HTR2C, HTR5A MAPT 2652/4885NPC1 4069/4885CYP11B1 1886/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback